A new market intelligence report by Transparency Market Research presents an overview of the global market for dry eye syndrome. The report, titled ‘Dry Eye Syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024,’ states that this market is expected to benefit from a rise in the occurrence of dry eye syndrome and the increasing aging population.
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10844
Dry eye syndrome, a chronic progressive condition, is caused due to the lack of tear liquid that lubricates the eyes. The medical term for dry eye syndrome is keratoconjunctivitis sicca. Dry eye syndrome is a common ocular disorder among aging people. Aging weakens the tear glands, resulting in the insufficient production of tear fluids. This promotes the development of dry eye syndrome. The regular use of contact lenses is also one of the primary causes of this eye disorder. A decrease in the production of tears also leads to dry eye syndrome in the elderly.
The treatment for dry eye syndrome depends and differs as per its severity and the cause. Dry eye syndrome, in most of the cases, can be successfully managed, resulting in minimized dryness in the eyes, improved eye comfort, and sharper vision. A combination of treatments such as artificial tears, warm compressors, punctal plugs, and steroid eye drops can be used to cure the dry eye syndrome. Artificial tears can help in minimizing the deficiency of tears to lubricate the eyes.
Warm compressors can help boost the activity of glands to produce more tears. Steroid eye drops are used to calm irritation around eyes to boost the natural production of tears. Punctal plugs are small medical devices inserted into the tear duct to prevent the drainage of eye liquid. With the presence of several remedial measures, more patients are projected to opt for dry eye syndrome treatments and therapeutics.
Currently, the global dry eye syndrome market is propelled by factors such as advancements in healthcare infrastructure, the availability of various treatments for dry eye syndrome, the rising awareness among people about eye disorders, and the growing government support towards medical research. However, the rising popularity of self-medication is predicted to hamper the global dry eye syndrome market. Leading players in the global dry eye syndrome market are taking efforts to spend more time on research to discover new drugs and treatments for dry eye syndrome. This is expected to benefit the global market in the years to come.
North America, Asia Pacific, Europe, and Rest of the World are the major regions in the global market for dry eye syndrome. At present, the global dry eye syndrome market is dominated by North America owing to the increasing occurrence of and treatment options for eye disorders. The increasing use of pain relievers, antidepressants, and antihistamines, leading to dry eye syndrome disorder is predicted to propel North America in the near future.
Novartis, Allergan Inc., Santen Pharmaceutical Co., Ltd., Nicox, and Bridge Pharma Inc. are some of the leading companies operating in the global dry eye syndrome market.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.Editor's Details
Last updated on: 21/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.